Every article, report, and earnings note where ALC appears.
Alcon is pairing strong Unity equipment momentum with faster dry-eye growth, while cash flow and buybacks support the bull case. Valuation is not cheap, but guidance and mix shift keep the stock constructive.
Tarsier Pharma Ltd. (NYSE: TARX) is expected to list on 2026-07-09, with 5,000,000 shares priced at $8.00 to $10.00 each. The company is a late-stage ophthalmic biotech with no product revenue yet, so the setup hinges on clinical progress rather than current sales.
Alcon Inc. (ALC) climbs more than 10% after hours on likely index-related buying and improving sentiment, with investors also positioning ahead of upcoming corporate events. The move follows a strong growth backdrop, but questions remain about whether the rally can hold into regular trading.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate ALC ReportCancel anytime